Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1960 1
1961 1
1962 2
1963 14
1964 8
1965 17
1966 13
1967 9
1968 12
1969 19
1970 20
1971 13
1972 17
1973 15
1974 27
1975 13
1976 25
1977 25
1978 30
1979 21
1980 31
1981 41
1982 46
1983 49
1984 61
1985 41
1986 65
1987 62
1988 69
1989 74
1990 62
1991 69
1992 57
1993 75
1994 80
1995 71
1996 98
1997 88
1998 91
1999 77
2000 89
2001 104
2002 125
2003 114
2004 104
2005 156
2006 124
2007 137
2008 148
2009 140
2010 157
2011 191
2012 197
2013 200
2014 217
2015 222
2016 220
2017 240
2018 290
2019 278
2020 328
2021 344
2022 339
2023 331
2024 87

Text availability

Article attribute

Article type

Publication date

Search Results

5,910 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.
Nakachi K, Ikeda M, Konishi M, Nomura S, Katayama H, Kataoka T, Todaka A, Yanagimoto H, Morinaga S, Kobayashi S, Shimada K, Takahashi Y, Nakagohri T, Gotoh K, Kamata K, Shimizu Y, Ueno M, Ishii H, Okusaka T, Furuse J; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Nakachi K, et al. Among authors: shimizu y. Lancet. 2023 Jan 21;401(10372):195-203. doi: 10.1016/S0140-6736(22)02038-4. Lancet. 2023. PMID: 36681415 Clinical Trial.
Myonectin protects against skeletal muscle dysfunction in male mice through activation of AMPK/PGC1α pathway.
Ozaki Y, Ohashi K, Otaka N, Kawanishi H, Takikawa T, Fang L, Takahara K, Tatsumi M, Ishihama S, Takefuji M, Kato K, Shimizu Y, Bando YK, Inoue A, Kuzuya M, Miura S, Murohara T, Ouchi N. Ozaki Y, et al. Among authors: shimizu y. Nat Commun. 2023 Aug 4;14(1):4675. doi: 10.1038/s41467-023-40435-2. Nat Commun. 2023. PMID: 37542026 Free PMC article.
Discovery of ^{39}Na.
Ahn DS, Amano J, Baba H, Fukuda N, Geissel H, Inabe N, Ishikawa S, Iwasa N, Komatsubara T, Kubo T, Kusaka K, Morrissey DJ, Nakamura T, Ohtake M, Otsu H, Sakakibara T, Sato H, Sherrill BM, Shimizu Y, Sumikama T, Suzuki H, Takeda H, Tarasov OB, Ueno H, Yanagisawa Y, Yoshida K. Ahn DS, et al. Among authors: shimizu y. Phys Rev Lett. 2022 Nov 18;129(21):212502. doi: 10.1103/PhysRevLett.129.212502. Phys Rev Lett. 2022. PMID: 36461972
IgA Nephropathy: Beyond the Half-Century.
Shimizu Y, Tomino Y, Suzuki Y. Shimizu Y, et al. Medicina (Kaunas). 2023 Dec 27;60(1):54. doi: 10.3390/medicina60010054. Medicina (Kaunas). 2023. PMID: 38256315 Free PMC article. Review.
Notch signaling drives intestinal graft-versus-host disease in mice and nonhuman primates.
Tkachev V, Vanderbeck A, Perkey E, Furlan SN, McGuckin C, Gómez Atria D, Gerdemann U, Rui X, Lane J, Hunt DJ, Zheng H, Colonna L, Hoffman M, Yu A, Outen R, Kelly S, Allman A, Koch U, Radtke F, Ludewig B, Burbach B, Shimizu Y, Panoskaltsis-Mortari A, Chen G, Carpenter SM, Harari O, Kuhnert F, Thurston G, Blazar BR, Kean LS, Maillard I. Tkachev V, et al. Among authors: shimizu y. Sci Transl Med. 2023 Jun 28;15(702):eadd1175. doi: 10.1126/scitranslmed.add1175. Epub 2023 Jun 28. Sci Transl Med. 2023. PMID: 37379368
5,910 results